ecabet has been researched along with Acute Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashiwagi, H; Omura, N; Tsuboi, K; Yanaga, K; Yano, F | 1 |
| Lawrance, IC | 1 |
| Adachi, S; Handa, O; Ichikawa, H; Kokura, S; Mizushima, K; Naito, Y; Okuda, T; Takagi, T; Uchiyama, K; Yoshikawa, T | 1 |
3 other study(ies) available for ecabet and Acute Disease
| Article | Year |
|---|---|
Effects of ecabet sodium on acute mixed reflux esophagitis in rats.
Topics: Abietanes; Acute Disease; Animals; Anti-Ulcer Agents; Disease Models, Animal; Esophagitis, Peptic; Male; Rats; Rats, Wistar; Severity of Illness Index; Treatment Outcome | 2009 |
Ecabet sodium: a potential new agent in the management of distal colitis.
Topics: Abietanes; Acute Disease; Animals; Anti-Ulcer Agents; Cell Movement; Colitis, Ulcerative; Colon; Extracellular Signal-Regulated MAP Kinases; Humans; Intestinal Mucosa; Phosphorylation; Rats; Wound Healing | 2010 |
Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
Topics: Abietanes; Acute Disease; Administration, Rectal; Animals; Anti-Ulcer Agents; Cell Line; Cell Movement; Colitis, Ulcerative; Colon; Disease Models, Animal; Enema; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Intestinal Mucosa; Male; Phosphorylation; Rats; Rats, Wistar; Time Factors; Trinitrobenzenesulfonic Acid; Wound Healing | 2010 |